(4-羧丁基)三苯基溴化膦

• 产品号: 157945
• CAS号: 17814-85-6
• 分子式: C23H24BrO2P
• 分子量: 443.313221
• 纯 度: 98%

产品别名

• 标题: (4-Carboxybutyl)triphenylphosphonium bromide
• IUPAC标准名: (4-carboxybutyl)triphenylphosphanium bromide
• IUPAC传统名: (4-carboxybutyl)triphenylphosphanium bromide
• 别名: 5-(Triphenylphosphonio)pentanoic acid bromide; NSC 147756; Carboxybutyltriphenylphosphonium bromide

产品登记号

• PubChem SID: 24849711
• EC号: 241-782-5
• MDL号: MFCD00011906
• CAS号: 17814-85-6
• Beilstein号: 3586477

产品性质

• 线性分子式: (C6H5)3P(Br)(CH2)4COOH
• 纯度: 98%
• 熔点: 204-207 °C(lit.)
• GHS警示词: Warning
• GHS危险声明: H315-H319-H335
• 欧盟危险性物质标志: 刺激性(Irritant) (Xi)
• 个人保护装置: dust mask type N95 (US), Eyeshields, Gloves
• GHS警示性声明: P261-P305 + P351 + P338
• 危险公开号: 36/37/38
• 安全公开号: 26-36
• 德国WGK号: 3

产品详细信息

详细说明 (English)

Packaging
10, 50, 250 g in poly bottle
Application

• Used as a platform for delivery of pro-apoptotic peptides into the mitochondria of tumor cells1Reactant for preparation of:
• Ring skeletons via ring closing metathesis and double bond migration ring closing metathesis reactions2
• Methyl alkenyl quinolones as antimycobacterial agents3
• Prostaglandins and their drug analogs via Gold-catalyzed Meyer-Schuster rearrangement4
• Diphenylmethylpiperazines as N-type calcium channel blockers as potential therapeutic agents5
• Folate receptor-specific glycinamide ribonucleotide formyltransferase (GARFTase) inhibitors with antitumor activity6
• Cycloalkylidene alkanols with antileishmanial activity, via Wittig reaction7

详细说明 (简体中文)

包装
10, 50, 250 g in poly bottle
Application

• Used as a platform for delivery of pro-apoptotic peptides into the mitochondria of tumor cells1Reactant for preparation of:
• Ring skeletons via ring closing metathesis and double bond migration ring closing metathesis reactions2
• Methyl alkenyl quinolones as antimycobacterial agents3
• Prostaglandins and their drug analogs via Gold-catalyzed Meyer-Schuster rearrangement4
• Diphenylmethylpiperazines as N-type calcium channel blockers as potential therapeutic agents5
• Folate receptor-specific glycinamide ribonucleotide formyltransferase (GARFTase) inhibitors with antitumor activity6
• Cycloalkylidene alkanols with antileishmanial activity, via Wittig reaction7